Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 12 of 27.
- T45.96XSUnderdosing of unspecified primarily systemic and hematological agent, sequela
- T46.0X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.0X6AUnderdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.0X6DUnderdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X6SUnderdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.1X5AAdverse effect of calcium-channel blockers, initial encounter
- T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounter
- T46.1X5SAdverse effect of calcium-channel blockers, sequela
- T46.1X6AUnderdosing of calcium-channel blockers, initial encounter
- T46.1X6DUnderdosing of calcium-channel blockers, subsequent encounter
- T46.1X6SUnderdosing of calcium-channel blockers, sequela
- T46.2X5AAdverse effect of other antidysrhythmic drugs, initial encounter
- T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounter
- T46.2X5SAdverse effect of other antidysrhythmic drugs, sequela
- T46.2X6AUnderdosing of other antidysrhythmic drugs, initial encounter
- T46.2X6DUnderdosing of other antidysrhythmic drugs, subsequent encounter
- T46.2X6SUnderdosing of other antidysrhythmic drugs, sequela
- T46.3X5AAdverse effect of coronary vasodilators, initial encounter
- T46.3X5DAdverse effect of coronary vasodilators, subsequent encounter
- T46.3X5SAdverse effect of coronary vasodilators, sequela
- T46.3X6AUnderdosing of coronary vasodilators, initial encounter
- T46.3X6DUnderdosing of coronary vasodilators, subsequent encounter
- T46.3X6SUnderdosing of coronary vasodilators, sequela
- T46.4X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
- T46.4X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequela
- T46.4X6AUnderdosing of angiotensin-converting-enzyme inhibitors, initial encounter
- T46.4X6DUnderdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
- T46.4X6SUnderdosing of angiotensin-converting-enzyme inhibitors, sequela
- T46.5X5AAdverse effect of other antihypertensive drugs, initial encounter
- T46.5X5DAdverse effect of other antihypertensive drugs, subsequent encounter
- T46.5X5SAdverse effect of other antihypertensive drugs, sequela
- T46.5X6AUnderdosing of other antihypertensive drugs, initial encounter
- T46.5X6DUnderdosing of other antihypertensive drugs, subsequent encounter
- T46.5X6SUnderdosing of other antihypertensive drugs, sequela
- T46.6X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
- T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.6X6AUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
- T46.6X6DUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
- T46.6X6SUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
- T46.7X5AAdverse effect of peripheral vasodilators, initial encounter
- T46.7X5DAdverse effect of peripheral vasodilators, subsequent encounter
- T46.7X5SAdverse effect of peripheral vasodilators, sequela
- T46.7X6AUnderdosing of peripheral vasodilators, initial encounter
- T46.7X6DUnderdosing of peripheral vasodilators, subsequent encounter
- T46.7X6SUnderdosing of peripheral vasodilators, sequela
- T46.8X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounter
- T46.8X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequela
- T46.8X6AUnderdosing of antivaricose drugs, including sclerosing agents, initial encounter
- T46.8X6DUnderdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
- T46.8X6SUnderdosing of antivaricose drugs, including sclerosing agents, sequela
- T46.905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
- T46.905DAdverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
- T46.905SAdverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
- T46.906AUnderdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
- T46.906DUnderdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
- T46.906SUnderdosing of unspecified agents primarily affecting the cardiovascular system, sequela
- T46.995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounter
- T46.995DAdverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
- T46.995SAdverse effect of other agents primarily affecting the cardiovascular system, sequela
- T46.996AUnderdosing of other agents primarily affecting the cardiovascular system, initial encounter
- T46.996DUnderdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
- T46.996SUnderdosing of other agents primarily affecting the cardiovascular system, sequela
- T47.0X5AAdverse effect of histamine H2-receptor blockers, initial encounter
- T47.0X5DAdverse effect of histamine H2-receptor blockers, subsequent encounter
- T47.0X5SAdverse effect of histamine H2-receptor blockers, sequela
- T47.0X6AUnderdosing of histamine H2-receptor blockers, initial encounter
- T47.0X6DUnderdosing of histamine H2-receptor blockers, subsequent encounter
- T47.0X6SUnderdosing of histamine H2-receptor blockers, sequela
- T47.1X5AAdverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
- T47.1X5DAdverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
- T47.1X5SAdverse effect of other antacids and anti-gastric-secretion drugs, sequela
- T47.1X6AUnderdosing of other antacids and anti-gastric-secretion drugs, initial encounter
- T47.1X6DUnderdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
- T47.1X6SUnderdosing of other antacids and anti-gastric-secretion drugs, sequela
- T47.2X5AAdverse effect of stimulant laxatives, initial encounter
- T47.2X5DAdverse effect of stimulant laxatives, subsequent encounter
- T47.2X5SAdverse effect of stimulant laxatives, sequela
- T47.2X6AUnderdosing of stimulant laxatives, initial encounter
- T47.2X6DUnderdosing of stimulant laxatives, subsequent encounter
- T47.2X6SUnderdosing of stimulant laxatives, sequela
- T47.3X5AAdverse effect of saline and osmotic laxatives, initial encounter
- T47.3X5DAdverse effect of saline and osmotic laxatives, subsequent encounter
- T47.3X5SAdverse effect of saline and osmotic laxatives, sequela
- T47.3X6AUnderdosing of saline and osmotic laxatives, initial encounter
- T47.3X6DUnderdosing of saline and osmotic laxatives, subsequent encounter
- T47.3X6SUnderdosing of saline and osmotic laxatives, sequela
- T47.4X5AAdverse effect of other laxatives, initial encounter
- T47.4X5DAdverse effect of other laxatives, subsequent encounter
- T47.4X5SAdverse effect of other laxatives, sequela
- T47.4X6AUnderdosing of other laxatives, initial encounter
- T47.4X6DUnderdosing of other laxatives, subsequent encounter
- T47.4X6SUnderdosing of other laxatives, sequela
- T47.5X5AAdverse effect of digestants, initial encounter
- T47.5X5DAdverse effect of digestants, subsequent encounter
- T47.5X5SAdverse effect of digestants, sequela